Skip to main content
. 2004 Jan;72(1):332–337. doi: 10.1128/IAI.72.1.332-337.2004

TABLE 1.

Serogroup C serum bactericidal antibody GMT with 95% CI and number of nonresponders with an SBA titer of <8, before and after one dose of MCC vaccine

Group Pre-MCC vaccination
Post-MCC vaccination
No. of patients No. with SBA titer of <8 (%) P value No. of patients GMT 95% CI P value No. with SBA titer of <8 (%) P value
Asplenic 90 67 (74) 116 157.8 94.5-263.3 23 (20)
    Sex
        Female 43 35 (81) 0.054 56 98.7 47.2-206.3 0.069 15 (27) 0.08
        Male 47 31 (66) 60 244.4 119.6-499.5 8 (13)
    Chronic illness
        Yes 26 21 (81) 0.38 35 84.4 30.9-230.8 0.13 10 (29) 0.13
        No 64 46 (72) 80 199.1 109.4-362.4 13 (16)
    Reason for removal of spleen
        Trauma 38 25 (66) 0.20 47 354.1 157.4-796.5 0.014 6 (13) 0.15
        Medical 46 36 (78) 59 92.1 45.1-188.0 14 (24)
    Time since splenectomy (yrs)
        <10 30 22 (73) 0.90 35 75.0 27.7-203.2 0.054 12 (34) 0.011
        ≥10 59 44 (75) 80 222.9 122.3-406.0 11 (14)
    Previous MACP
        Yes 24 14 (58) 0.038 35 98.9 37.7-259.6 0.30 7 (20) 0.95
        No 65 52 (80) 78 179.4 95.7-336.2 16 (21)
    Antibiotics
        Yes 42 33 (79) 0.40 54 185.7 90.5-381.2 0.56 8 (15) 0.21
        No 48 34 (71) 62 136.9 65.1-287.6 15 (24)
Control 48 25 (52) 0.008b 48 1448.2 751.1-2792.0 <0.001a 1 (2) 0.003b
a

Compared with all asplenic individuals.

b

Determined by Fisher's exact test of the results for the controls versus those for all asplenics.